Hodgkin lymphoma in a child with sickle cell anemia

Pediatric Hematology and Oncology

Volumn 24, Issue 7, 2007, Pages 531-535

  Brown, Biobele J ^a,b   Kotila, Taiwo R ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Chemotherapy; Co existence; Hodgkin lymphoma; Sickle cell anemia

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; ISONIAZID; PREDNISOLONE; PROCARBAZINE; PROGUANIL; VINCRISTINE;

ANAMNESIS; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LYMPH NODE BIOPSY; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PAIN; PHYSICAL EXAMINATION; SCHOOL CHILD; SEPSIS; SEPTICEMIA; SICKLE CELL ANEMIA; SINUS HISTIOCYTOSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANEMIA, SICKLE CELL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHLOROGUANIDE; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; HODGKIN DISEASE; HUMANS; MALE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

EID: 34548435233     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010701533637     Document Type: Article

References (15)

1. Stricker RB, Linker CA, Crowley TJ, Embury SH. hematologic malignancy in sickle cell disease: report of four cases and review of the literature. Am J Hematol. 1986;21:223-230.
2. Paydas S. Sickle cell anemia and hematological neoplasias. Leuk Lymphoma. 2002;43:1431-1434.
3. Salmassi S, Currie ET, Bolf EC, Hernandez M, Kasprisin DO. Management of Hodgkin's disease in a patient with sickle cell anemia. Cancer. 1981;48:252-254.
4. Moschovi M, Psychou F, Menegas D, Th Tsangaris G, Tzortzatou-Stathopoulou F, Nikolaidou P. Hodgkin's disease in a child with sickle cell disease treated with hydroxyurea. Pediatr Hematol Oncol. 2001;18:371-376.
5. Morabito F, Callea V, Brugiatelli M, D'Ascola D, Palazzolo A, Neri A. Non-Hodgkin's lymphoma associated with sickle cell disease: a case report. Tumori. 1987;73:523-524.
6. Schultz WH. Ware RE for the International Association of Sickle Cell Nurses and Physician Assistants. Malignancy in patients with sickle cell disease. Am J Hematol. 2003;74:249-253.
7. Bering HA, Duttagupta S, Lebowitz P. Proto-oncogene expression during erythroid proliferation. Clin Res. 1984;32:304A (Abstract).
8. Milner PF. The sickling disorders. Clin Haematol. 1974;3:289.
9. Little JB. Influence of noncarcinogenic secondary factors on radiation carcinogenesis. Radiat Res. 1981;87:240.
10. Amusa YB, Adediran IA, Akinpelu VO, et al. Burkitt's lymphoma of the head and neck in a Nigerian tertiary hospital. West Afr J Med. 2005;24:139-142.
11. Lannert K, Hansman ML. Progressive transformation of germinal centers: clinical significance and lymphocytic predominance Hodgkin's disease: the Kiel experience. Am J Surg Pathol. 1987;11:149-150.
12. Zarate-Osorno A, Modeiros LJ, Kingma DW, Longo DL, Jaffe ES. Hodgkin's disease following non-Hodgkin's lymphoma: a clinicopathologic and immunophenotypic study of nine cases. Am J Surg Pathol. 1993;17:123-132.
13. Maia DM, Dorfman RF. Focal changes of sinus histiocytosis with massive lymphadenopathy (Rsai-Dorfman disease) associated with nodular lymphocyte predominant Hodgkin's disease. Hum Pathol. 1995;26:1378-1382.
14. Kotila TR, Aken'Ova YA, Shokunbi WA, Akingbola TS, Fasola FA. Hodgkin's disease after treatment for Burkitt's lymphoma: case report. East Afr Med J. 2001;78:49-51.
15. Kotila TR, Shokunbi WA. Survival advantage in female patients with sickle cell anaemia. East Afr Med J. 2001;78:33-35.